Primary Hyperoxaluria News and Research

RSS
Polycystic kidney disease may be preventable

Polycystic kidney disease may be preventable

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

UCLA research may lead to novel treatment for PH1

UCLA research may lead to novel treatment for PH1

Oxabact now recognized as potential treatment for Short Bowel Syndrome

Oxabact now recognized as potential treatment for Short Bowel Syndrome

OxThera granted new patents for treatment of hyperoxaluria

OxThera granted new patents for treatment of hyperoxaluria

OxThera announces initiation of Oxabact clinical study in Primary Hyperoxaluria

OxThera announces initiation of Oxabact clinical study in Primary Hyperoxaluria

OxThera granted Japanese patents for treating oxalate-related disease

OxThera granted Japanese patents for treating oxalate-related disease

AUA podium session on stone disease

AUA podium session on stone disease

Pharmacogenomics used to treat inherited kidney disorder of children

Pharmacogenomics used to treat inherited kidney disorder of children